Altamira Therapeutics Ltd (CYTO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2006 | 09-2006 | 06-2006 | 03-2006 | 12-2005 | |
| Gross Profit | 2,070 | 1,490 | 1,570 | 2,020 | 1,700 |
| Operating Expenses | 1,870 | 990 | 1,460 | 2,980 | 2,230 |
| Operating Income | -1,870 | -990 | -1,460 | -2,980 | -2,230 |
| Pre-tax Income | -1,870 | -990 | -1,460 | -2,980 | -2,230 |
| Net Income Continuous | -1,870 | -990 | -1,460 | -2,980 | -2,230 |
| Net Income | $-1,870 | $-990 | $-1,460 | $-2,980 | $-2,230 |
| EBITDA(a) | $-1,440 | $-660 | $-1,140 | $-2,700 | $-1,960 |